Prenatal stem cell treatment targets rare genetic disease before birth

Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving treatments for rare blood disorders. She’s an expert in Fanconi anemia, a genetic disease that interferes with DNA repair and blood cell production. By age 12, most people with the disease experience a life-threatening complication called bone marrow failure, in which the body’s blood-cell factory stops functioning.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup